Cervical carcinoma: A comparison of four potential biochemical tumor markers
- 18 February 1989
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 32 (2) , 248-252
- https://doi.org/10.1016/s0090-8258(89)80043-5
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The value of the monoclonal antibody (cancer antigen 125) in serial monitoring of ovarian cancer: a comparison with circulating immune complexesBJOG: An International Journal of Obstetrics and Gynaecology, 1985
- Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial Determinations and Tissue LocalizationCancer, 1985
- Tumor-antigen TA-4 in the detection of recurrence in cervical squamous cell carcinomaCancer, 1984
- Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervixAmerican Journal of Obstetrics and Gynecology, 1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Circulating IgG-specific immune complexes as a potential tumor marker in gynecological malignanciesGynecologic Oncology, 1983
- Prognostic significance of the tumor antigen TA-4 in squamous cell carcinoma of the uterine cervixAmerican Journal of Obstetrics and Gynecology, 1983
- Tumor‐Antigen (TA‐4) of Squamous Cell Carcinomaits Tissue Distribution and its Relationship to Serum TA‐4 ConcentrationsAsia-Oceania Journal of Obstetrics and Gynaecology, 1980
- Carcinoembryonic Antigen Levels in Patients With Squamous Cell Carcinoma of the CervixObstetrics & Gynecology, 1978
- Radioimmunoassay for tumor antigen of human cervical squamous cell carcinomaCancer, 1977